Politics

Supreme Court declines to hear challenge to marijuana’s Schedule I status

Published on October 13, 2020
supreme-court-declines-marijuana-legalization-case
The U.S. Supreme Court has declined to hear 'Washington v. Barr,' a case that challenges the federal Schedule I classification of cannabis. (AdobeStock)

The U.S. Supreme Court has declined to consider Washington v. Barr, a case that challenged the federal Schedule I status of cannabis. The news came in a routine Supreme Court announcement earlier this morning. The court listed Washington v. Barramong the many cases that were denied certiorari.

The court’s action wasn’t surprising, but it came as a disappointment to the many plaintiffs and lawyers who have been working on the case for more than three years.

The lawsuit began in 2017, when it was called Washington v. Sessions, because Jeff Sessions was then the U.S. Attorney General. Five plaintiffs, including former NFL player Marvin Washington; 12-year-old Colorado medical refugee Alexis Bortell; youngster Jagger Cotte; US military veteran Jose Belen; and the Cannabis Cultural Association, a nonprofit that helps people of color benefit from cannabis in states where it’s legal, challenged the constitutionality of the classification of marijuana under the federal Controlled Substances Act. The case received its first hearing in federal court in 2018.

Leading the case was David C. Holland, a litigator in New York City and the executive and legal director of Empire State NORML. He’s former counsel to High Times Magazine and a member of the New York Cannabis Bar Association.

Hoping for a hearing before the highest court

The case had been rejected in a series of lower federal court rulings. Plaintiffs had hoped to secure certiorari before the U.S. Supreme Court and force the nation’s highest court to confront the baseless standing of marijuana’s Schedule I classification.

Sebastien Cotte, whose son Jagger was a plaintiff in the case, told Marijuana Moment associate editor Kyle Jaeger: “While not surprising, as less than one percent of all petitions to the Supreme Court get a hearing, it is still very disappointing, as we been fighting for this case for over three years now.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Sign up for more Leafly news

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.